The study found that between 2019 and 2023, there was an overall 45% decline in anesthesia-based applicants to pain medicine fellowships.

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

The following is a summary of “Preoperative Ketamine Gargle for Prevention of Postoperative Sore Throat After Tracheal ...

Mayor Eric Adams admitted Wednesday he went under anesthesia last week during his still-undisclosed mystery illness. Adams refused to detail the specific ailment that kept him uncharacteristically out ...

The number of anesthesiology residents applying to pain medicine decreased 45 percent from 2019 to 2023, according to a study ...

Employees have left or have gone unpaid as the Anesco anesthesia group loses its contract with Broward Health hospitals amid ...

The study highlights a concerning 45% decline in pain medicine fellowship applications, pointing to workforce issues and ...

Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...

The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.